PlainRecalls
FDA Drug Low Class III Terminated

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.

Reported: March 20, 2019 Initiated: March 7, 2019 #D-0991-2019

Product Description

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.

Reason for Recall

Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

Details

Units Affected
112 folding cartons
Distribution
Nationwide in the USA
Location
Ridgefield, CT

Frequently Asked Questions

What product was recalled?
Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.. Recalled by Boehringer Ingelheim Pharmaceuticals, Inc.. Units affected: 112 folding cartons.
Why was this product recalled?
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2019. Severity: Low. Recall number: D-0991-2019.